2019
DOI: 10.1002/cbin.11123
|View full text |Cite
|
Sign up to set email alerts
|

Progesterone and fluoxetine treatments of postpartum depressive‐like behavior in rat model

Abstract: Research studies have indicated that alterations in plasma progesterone levels might be associated with the hippocampal synaptic plasticity of postpartum depressive-like behavior. Herein, we assess both progesterone and fluoxetine effects in adult female Sprague-Dawley rats with postpartum depressive-like behavior. Depressive-like behavior of postpartum rats was established using chronic ultra-mild stress (CUMS) method for 1 week from gestation day 15. Postpartum rats that showed depressive-like behavior were … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 12 publications
(8 citation statements)
references
References 52 publications
1
7
0
Order By: Relevance
“…Nestin-positive cells, as the proliferative progenitor neural cells (28), and MAP-2-positive cells, as the mature neurons, were enhanced after treatment with fluoxetine or JYCF. These findings were consistent with previous research on gradually improving depression (29). BDNF, a kind of the nerve growth factor, possesses the ability to support neuronal survival, differentiation, function and plasticity and has been observed to play a crucial role in certain neurobiological modifications that may otherwise lead to depression (30); CUMS exposure significantly decreased BDNF level in hippocampi, suggesting the involvement of BDNF in the pathology of depression, and treatment with fluoxetine and JYCF reversed CUMSinduced decrease in BDNF, which provided another possible mechanism of action for the antidepressant-like activity of JYC.…”
Section: Discussionsupporting
confidence: 93%
“…Nestin-positive cells, as the proliferative progenitor neural cells (28), and MAP-2-positive cells, as the mature neurons, were enhanced after treatment with fluoxetine or JYCF. These findings were consistent with previous research on gradually improving depression (29). BDNF, a kind of the nerve growth factor, possesses the ability to support neuronal survival, differentiation, function and plasticity and has been observed to play a crucial role in certain neurobiological modifications that may otherwise lead to depression (30); CUMS exposure significantly decreased BDNF level in hippocampi, suggesting the involvement of BDNF in the pathology of depression, and treatment with fluoxetine and JYCF reversed CUMSinduced decrease in BDNF, which provided another possible mechanism of action for the antidepressant-like activity of JYC.…”
Section: Discussionsupporting
confidence: 93%
“…Clinical and preclinical studies have demonstrated that progesterone exerted antidepressant (-like) effect (Gordon et al 2018;Hu et al 2019). As evidence for their importance to the brain, progesterone and allopregnanolone are produced not only by peripheral glands (e.g., ovary; adrenal gland), but also by the brain itself (Wirth 2011).…”
Section: Discussionmentioning
confidence: 99%
“…Administrating both progesterone and Fluoxetine treatments increase the numbers of dendritic spines pyramidal neurons in the CA3 region of the hippocampus as well as protein expression levels of microtubule-associated protein 2 (MAP-2) and synaptophysin (SYP). CUMS-induced decrement of MAP-2 and SYP protein expressions can be prevented by treatment with progesterone in advanced pregnant stage and Fluoxetine in the postpartum period (32).…”
Section: Hormonal Treatment Options In Postpartum Disordersmentioning
confidence: 99%